PUBLISHER: TechNavio | PRODUCT CODE: 1072794
PUBLISHER: TechNavio | PRODUCT CODE: 1072794
Technavio has been monitoring the POC molecular diagnostics market and it is poised to grow by $ 1.83 bn during 2022-2026, accelerating at a CAGR of 14.67% during the forecast period. Our report on the POC molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing geriatric population, increase in adoption of microarrays in genomics and proteomics, and increased focus on personalized medicine.
The POC molecular diagnostics market analysis includes the product, application segment, and geographic landscape.
Technavio's POC molecular diagnostics market is segmented as below:
By Product
By Application
By Geographical Landscape
This study identifies the growing focus on technological advances as one of the prime reasons driving the POC molecular diagnostics market growth during the next few years. Also, the presence of government funding and a growing number of cancer cases worldwide will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on POC molecular diagnostics market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading POC molecular diagnostics market vendors that include Abbott Laboratories, Becton Dickinson and Co., Binx Health Inc., Co-Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., gene drive plc, Lucira Health Inc., Molbio Diagnostics Pvt. Ltd., OraSure Technologies Inc., QIAGEN NV, QuantuMDx Group Ltd., Randox Laboratories Ltd., Robert Bosch GmbH, Siemens AG, Sysmex Corp., Talis Biomedical Corp., Thermo Fisher Scientific Inc., bioMerieux SA, and Quidel Corp. Also, the POC molecular diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: